GILUPI GmbH Sustainability Profile
GILUPI GmbH, headquartered in Germany, is a pioneering company in the field of medical technology, specialising in innovative solutions for cancer diagnostics. Founded in 2006, GILUPI has made significant strides in the industry, particularly with its flagship product, the GILUPI CellCollector, which enables the capture of circulating tumour cells (CTCs) from blood samples. This unique technology enhances early cancer detection and monitoring, setting GILUPI apart in the competitive landscape of oncology diagnostics. With a strong presence in Europe and expanding operations globally, GILUPI is recognised for its commitment to advancing personalised medicine. The company has achieved notable milestones, including collaborations with leading research institutions, further solidifying its position as a key player in the medical technology sector. GILUPI continues to drive innovation, aiming to improve patient outcomes through its cutting-edge diagnostic solutions.
DitchCarbon Score
How does GILUPI GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GILUPI GmbH's score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
GILUPI GmbH's reported carbon emissions
GILUPI GmbH, headquartered in Germany, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of reported figures. The company is classified as a current subsidiary and does not inherit emissions data from a parent organization. In terms of climate commitments, GILUPI GmbH has not outlined any specific reduction targets or initiatives, nor does it participate in recognised frameworks such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). The lack of documented climate pledges or reduction strategies suggests that the company may still be in the early stages of developing its sustainability and emissions reduction plans. As the industry increasingly prioritises climate action, GILUPI GmbH may need to establish clear targets and reporting mechanisms to align with global standards and expectations.
How Carbon Intensive is GILUPI GmbH's Industry?
How Carbon Intensive is GILUPI GmbH's Location?
GILUPI GmbH's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
GILUPI GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
